Gilman, S.
Brigham and Women's Hospital · Brown University · Butler Hospital · Ontario Shores Centre for Mental Health Sciences · University of Rochester Medicine · Yale University · Monroe Community Hospital
6 papers on CoChat
Most cited papers
- Verified
Second consensus statement on the diagnosis of multiple system atrophy
Gilman, S., Wenning, G. K., Low, P. A., Brooks, D. J., Mathias, C. J., Trojanowski, J. Q., Wood, N. W., Colosimo, C., Dürr, A., Fowler, C. J., et al. (2008) · Neurology
Parkinson's Disease Mechanisms and TreatmentsNeurological diseases and metabolism
Cited by 3,140
- Verified
Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization
Orgogozo, J.-M., Gilman, S., Dartigues, J.-F., Laurent, B., Puel, M., Kirby, L. C., Jouanny, P., Dubois, B., Eisner, L., Flitman, S., et al. (2003) · Neurology
Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 1,356
- Verified
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
Gilman, S., Koller, M., Black, R. S., Jenkins, L., Griffith, S. G., Fox, N. C., Eisner, L., Kirby, L., Rovira, M. B., Forette, F., et al. (2005) · Neurology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 1,329
- Verified
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
Salloway, S., Sperling, R., Gilman, S., Fox, N. C., Blennow, K., Raskind, M., Sabbagh, M., Honig, L. S., Doody, R., van Dyck, C. H., et al. (2009) · Neurology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 753
- Verified
Effects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease
Fox, N. C., Black, R. S., Gilman, S., Rossor, M. N., Griffith, S. G., Jenkins, L., & Koller, M. (2005) · Neurology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 550
- Verified
A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease
Salloway, S., Sperling, R., Keren, R., Porsteinsson, A. P., van Dyck, C. H., Tariot, P. N., Gilman, S., Arnold, D., Abushakra, S., Hernandez, C., et al. (2011) · Neurology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 258
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free